Federal Register #2026-15387

EPA Request for Public Comment on Information Collection for Hazardous Waste Pharmaceuticals Management Standards (Renewal)

The Environmental Protection Agency (EPA) is seeking public comment on the renewal of its Information Collection Request (ICR) for hazardous waste pharmaceuticals management standards. - Government Buyer: - Environmental Protection Agency (EPA) - OEMs and Vendors: - No specific OEMs or vendors are mentioned; this is a regulatory information collection, not a product or service procurement. - Products/Services Requested: - Collection of information from healthcare facilities and reverse distributors regarding management of hazardous waste pharmaceuticals - Includes mandatory reporting, tracking, labeling, manifest management, and exception reporting - Estimated 8,163 respondents annually - Estimated annual burden: 40,045 hours and $3,580,140 in costs - Unique or Notable Requirements: - Applies to healthcare facilities and reverse distributors handling hazardous waste pharmaceuticals - Focus on compliance with EPA regulations under 40 CFR part 266, subpart P - Information collection is required for regulatory oversight and compliance, not for procurement of goods or services

Description

The Environmental Protection Agency (EPA) is planning to submit an information collection request (ICR) titled "Management Standards for Hazardous Waste Pharmaceuticals (Renewal)" to the Office of Management and Budget (OMB) for review and approval. This is a proposed extension of the current ICR, which is approved through March 31, 2027. The EPA is seeking public comments on the proposed ICR, with comments due by September 28, 2026. The ICR concerns management standards for hazardous waste pharmaceuticals and includes regulations for healthcare facilities and reverse distributors.

View original listing